Monday, October 22, 2018
- 9:00AM-11:00AM
-
Abstract Number: 1568
Azathioprine and Mycophenolate for Management of Sjögren’s Syndrome-Related Interstitial Lung Disease: A Retrospective Cohort Study
Sjögren's Syndrome – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1561
B Lymphocyte Depletion Therapy with Rituximab in Primary Sjögren’s Syndrome: Indications , Effectiveness and Ultrasonographic Response
Sjögren's Syndrome – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1518
Baricitinib and Tofacitinib in Real Life – Does Obesity Impact Response to Janus Kinase Inhibitor Therapy in Rheumatoid Arthritis?
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1526
Baseline Characteristics and Outcomes in Patients with Anemia in Clinical Studies of Tofacitinib
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1495
Baseline Characteristics of Methotrexate Inadequate Responder Patients with RA Who Achieved Low Disease Activity with Tofacitinib Monotherapy
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis- 9:00AM-11:00AM
-
Abstract Number: 1802
Behcet’s Disease in the Southwestern United States
Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease- 9:00AM-11:00AM
-
Abstract Number: 1459
Bone Erosion Volume Changes Measured By HR-pQCT at 3-Months after Initiation of Anti-TNF Treatment Predicted Erosion Volume Changes at 1-Year in RA
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis- 9:00AM-11:00AM
-
Abstract Number: 1597
Bone Mineral Density and Serum Biomarkers of Bone Turnover in Ankylosing Spondylitis Patients Treated with Secukinumab: 2-Year Data from the Pivotal Phase 3 Study
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies- 9:00AM-11:00AM
-
Abstract Number: 1755
Burden of Illness Associated with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome): Evidence from a Managed Care Database in the United States
Vasculitis – ANCA-Associated Poster I- 9:00AM-11:00AM
-
Abstract Number: 1283
Calcium Pyrophosphate Crystal Deposition in a Cohort of 48 Patients with Gitelman Syndrome
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I- 9:00AM-11:00AM
-
Abstract Number: 1139
Can Body Composition Explain the Sex Disparity in Risk of Osteoarthritis?
Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function- 9:00AM-11:00AM
-
Abstract Number: 1258
Can Patients Enter Medical History Data By Self-Report Directly into an Electronic Medical Record (EMR)? “Private Medical History” (PMH) Software for Physician Report in EMR Format and Patient Storage to Correct and Update Medical History for Any EMR
Measures and Measurement of Healthcare Quality Poster II- 9:00AM-11:00AM
-
Abstract Number: 1164
Canadians’ Views about Using Big Data in Health Research from a National Online Survey: A Partnership of Patient-Consumers and Researchers
Epidemiology and Public Health Poster II – ARHP- 9:00AM-11:00AM
-
Abstract Number: 1325
Canakinumab Treatment in Adult-Onset Still’s Disease: Case Series